News
Taking anti-platelet medication longer than current recommendations may lower heart attack or death risks for patients ...
December 06, 2006
News
The FDA was notified on Dec. 2 that Pfizer will suspend a large, Phase 3 trial evaluating the investigational ...
December 05, 2006News
The FDA will revisit a device tomorrow that it cleared for U.S. sale three years ago — drug-eluting stents will be the ...
December 05, 2006Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
The American Heart Association has published a report demonstrating that adolescent boys have a significantly increased ...
December 05, 2006
Feature | Judy Harvey
Pulse oximetry, which directly monitors the patient's oxygenation, came into its own as standard medical practice 20 ...
December 04, 2006News
The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...
December 04, 2006Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
Case Study
One of the major dilemmas faced by clinicians in the Intensive Care Unit (ICU) is the determination of volume status and ...
December 04, 2006News
Toronto-based Cedara Software, a Merge Healthcare company and an independent developer of medical software technologies ...
December 04, 2006News
Recent downplay of the media’s attention to DES-related thrombosis during both the TCT and AHA conferences this fall may ...
December 04, 2006Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
CV Therapeutics has announced it will file a new drug application to the FDA for its regadenoson agent in mid-2007 ...
December 04, 2006News
AngioDynamics, Inc. has announced FDA 510(k) clearance for Oncobionic, Inc. to market Irreversible Electroporation (IRE) ...
December 03, 2006News
Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.
December 03, 2006Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...
December 03, 2006News
Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”
December 03, 2006News
An implantable technology to control high blood pressure in patients not responding to available medicines has ...
November 29, 2006